Selective Inhibition of Histone Deacetylase Class IIa With MC1568 Ameliorates Podocyte Injury
Histone deacetylases (HDACs) inhibitors are promising therapeutic agents against proteinuric kidney diseases, here, we investigated the effect of MC1568, a selective inhibitor of HDAC class IIa, on the development and progression of nephrotic syndrome in a murine model induced by Adriamycin (ADR). I...
Main Authors: | Xu He, Tao Sun, Pei Zhang, Zhengkun Xia, Chunlin Gao, Hongqi Ren, Daxi Ji |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.848938/full |
Similar Items
-
Nonimmunologic targets of immunosuppressive agents in podocytes
by: Tae-Hyun Yoo, et al.
Published: (2015-06-01) -
Podocyte specific deletion of PKM2 ameliorates LPS-induced podocyte injury through beta-catenin
by: Mohammed Alquraishi, et al.
Published: (2022-05-01) -
Comparison between outcomes of IgA nephropathy with nephrotic-range proteinuria and nephrotic syndrome: do podocytes play a role?
by: Yizhen Chen, et al.
Published: (2022-12-01) -
Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho
by: Min Liu, et al.
Published: (2023-12-01) -
Podocyte Endocytosis in Regulating the Glomerular Filtration Barrier
by: Xuefei Tian, et al.
Published: (2022-02-01)